4-(2-amino-8,9,10,11-tetrahydro-6H-imidazo[4,5-a]phenanthridin-7-yl)phenol;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethanimidamide;bis(4-(6,7,8,9-tetrahydro-1H-pyrazolo[4,5-c]isoquinolin-5-yl)phenol);4-(9,13,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,14,16-hexaen-8-yl)phenol
C94H86N18O4 — CID 158143729
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(2-amino-8,9,10,11-tetrahydro-6H-imidazo[4,5-a]phenanthridin-7-yl)phenol;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethanimidamide;bis(4-(6,7,8,9-tetrahydro-1H-pyrazolo[4,5-c]isoquinolin-5-yl)phenol);4-(9,13,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,14,16-hexaen-8-yl)phenol
4-(2-amino-8,9,10,11-tetrahydro-6H-imidazo[4,5-a]phenanthridin-7-yl)phenol;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethanimidamide;bis(4-(6,7,8,9-tetrahydro-1H-pyrazolo[4,5-c]isoquinolin-5-yl)phenol);4-(9,13,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,14,16-hexaen-8-yl)phenol (PubChem CID 158143729) has the molecular formula C94H86N18O4 and a molecular weight of 1531.84 g/mol. Its IUPAC name is 4-(2-amino-8,9,10,11-tetrahydro-6H-imidazo[4,5-a]phenanthridin-7-yl)phenol;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethanimidamide;bis(4-(6,7,8,9-tetrahydro-1H-pyrazolo[4,5-c]isoquinolin-5-yl)phenol);4-(9,13,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,14,16-hexaen-8-yl)phenol.
Molecular Properties
| Compound Name | 4-(2-amino-8,9,10,11-tetrahydro-6H-imidazo[4,5-a]phenanthridin-7-yl)phenol;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethanimidamide;bis(4-(6,7,8,9-tetrahydro-1H-pyrazolo[4,5-c]isoquinolin-5-yl)phenol);4-(9,13,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,14,16-hexaen-8-yl)phenol |
|---|---|
| PubChem CID | 158143729 |
| Molecular Formula | C94H86N18O4 |
| Molecular Weight | 1531.84 g/mol |
| Exact Mass | 1530.71 |
| IUPAC Name | 4-(2-amino-8,9,10,11-tetrahydro-6H-imidazo[4,5-a]phenanthridin-7-yl)phenol;2-[4-(8,9,10,11-tetrahydro-3H-pyrazolo[4,5-a]phenanthridin-7-yl)phenyl]ethanimidamide;bis(4-(6,7,8,9-tetrahydro-1H-pyrazolo[4,5-c]isoquinolin-5-yl)phenol);4-(9,13,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(10),2(7),8,11,14,16-hexaen-8-yl)phenol |
| SMILES | Nc1nc2ccc3[nH]c(-c4ccc(O)cc4)c4c(c3c2n1)CCCC4.Oc1ccc(-c2nc3ccn4nccc4c3c3c2CCCC3)cc1.Oc1ccc(-c2nc3cn[nH]c3c3c2CCCC3)cc1.Oc1ccc(-c2nc3cn[nH]c3c3c2CCCC3)cc1.[H]/N=C(\N)Cc1ccc(-c2nc3ccc4[nH]ncc4c3c3c2CCCC3)cc1 |
| InChI | InChI=1S/C22H21N5.C20H18N4O.C20H17N3O.2C16H15N3O/c23-20(24)11-13-5-7-14(8-6-13)22-16-4-2-1-3-15(16)21-17-12-25-27-18(17)9-10-19(21)26-22;21-20-23-16-10-9-15-17(19(16)24-20)13-3-1-2-4-14(13)18(22-15)11-5-7-12(25)8-6-11;24-14-7-5-13(6-8-14)20-16-4-2-1-3-15(16)19-17(22-20)10-12-23-18(19)9-11-21-23;2*20-11-7-5-10(6-8-11)15-12-3-1-2-4-13(12)16-14(18-15)9-17-19-16/h5-10,12H,1-4,11H2,(H3,23,24)(H,25,27);5-10,22,25H,1-4H2,(H2,21,23);5-12,24H,1-4H2;2*5-9,20H,1-4H2,(H,17,19) |
| InChIKey | LSJDCTYBBGGBMP-UHFFFAOYSA-N |
| XLogP | 18.63 |
| TPSA | 353.28 Ų |
| H-Bond Donors | 11 |
| H-Bond Acceptors | 17 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 116 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1531.84 |
| LogP ≤ 5 | 18.63 |
| H-Bond Donors ≤ 5 | 11 |
| H-Bond Acceptors ≤ 10 | 17 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158143729 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.